Cyanotech Corporation

The momentum for this stock is not very good. Cyanotech Corporation is not very popular among insiders. Tradey thinks it is not wise to invest in Cyanotech Corporation.
Log in to see more information.
Cyanotech Corp. develops and commercializes natural products from microalgae. It produces BioAstin n...

News

Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%
Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%

Simply Wall St Cyanotech Corporation ( NASDAQ:CYAN ) shareholders won't be pleased to see that the share price has had a very rough...\n more…

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?
Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Simply Wall St Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...\n more…

Cyanotech Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.095 loss in 3Q 2023)
Cyanotech Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.095 loss in 3Q 2023)

Simply Wall St Cyanotech ( NASDAQ:CYAN ) Third Quarter 2024 Results Key Financial Results Revenue: US$5.58m (down 5.2% from 3Q 2023...\n more…

Michael Davis Bought 42% More Shares In Cyanotech
Michael Davis Bought 42% More Shares In Cyanotech

Simply Wall St Potential Cyanotech Corporation ( NASDAQ:CYAN ) shareholders may wish to note that the Independent Chairman of the...\n more…

Cyanotech Second Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.15 loss in 2Q 2023)
Cyanotech Second Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.15 loss in 2Q 2023)

Simply Wall St Cyanotech ( NASDAQ:CYAN ) Second Quarter 2024 Results Key Financial Results Revenue: US$6.37m (up 23% from 2Q 2023...\n more…

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024

Business Wire Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2024, ended June 30, 2023. Commenting on the first quarter fiscal year 2024 results...\n more…